Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VANISH-1: Polidocanol injectable foam for varicose veins
NCT01072877Phase 3Completed
- Sponsor
- Boston Scientific Corporation
- Start
- Dec 2010
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of 10XB101 in Varicose Veins, sponsored by Boston Scientific Corporation. Started Dec 2010; status: completed.
02
Drugs
10XB101
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on NCT01072877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01072877.